We are a Hamburg-based biotechnology startup that provides top-quality tests for tropical and emerging infectious diseases. Together with our partner, Bernhard Nocht Institute for Tropical Medicine, we develop immunoassays for antibody detection in human samples. Leveraging our patented technology platform, our immunoassay tests have superior specificity and sensitivity, especially targeting the priority diseases in the WHO blueprint list.We empower scientists, researchers, and health authorities for their tasks of outbreak monitoring, infection surveillance, and seroprevalence studies.
Profile provided by Panadea Diagnostics GmbH.
Disclaimer: Company data is provided by Dealroom and startupdetector UG Berlin (www.startupdetector.de), except "About" text, header image, "About" image, email address and phone number.
Stay updated - sign up for our Newsletter!
Subscribe Now
